Loading...
ANUHPHR logo

Anuh Pharma LimitedNSEI:ANUHPHR Stock Report

Market Cap ₹7.9b
Share Price
n/a
1Y-17.1%
7D0.5%
1D-0.3%
Portfolio Value
​
View

Anuh Pharma Limited

NSEI:ANUHPHR Stock Report

Market Cap: ₹7.9b

Anuh Pharma (ANUHPHR) Stock Overview

Engages in the manufacture and sale of bulk drugs and chemicals in India. More details

ANUHPHR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Rewards

Price-To-Earnings ratio (19.4x) is below the Indian market (23.2x)

Risk Analysis

Does not have a meaningful market cap (₹8B)

Dividend of 1.89% is not well covered by free cash flows


ANUHPHR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW481,017 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
481,017 investors already sharing narratives
View all narratives

Anuh Pharma Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Anuh Pharma
Historical stock prices
Current Share Price₹79.48
52 Week High₹96.43
52 Week Low₹67.00
Beta0.43
1 Month Change-1.21%
3 Month Change-0.54%
1 Year Change-17.12%
3 Year Changen/a
5 Year Changen/a
Change since IPO-28.67%

Recent News & Updates

Recent updates

Analysis Article • Feb 04

Lacklustre Performance Is Driving Anuh Pharma Limited's (NSE:ANUHPHR) Low P/E

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 24x, you may consider Anuh...
Analysis Article • Oct 28

Anuh Pharma Limited's (NSE:ANUHPHR) Earnings Are Not Doing Enough For Some Investors

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 28x, you may consider Anuh...
Analysis Article • Aug 06

We Think That There Are More Issues For Anuh Pharma (NSE:ANUHPHR) Than Just Sluggish Earnings

NSEI:ANUHPHR 1 Year Share Price vs Fair Value Explore Anuh Pharma's Fair Values from the Community and select yours The...
Analysis Article • May 31

Anuh Pharma Limited's (NSE:ANUHPHR) Shares Bounce 26% But Its Business Still Trails The Market

Despite an already strong run, Anuh Pharma Limited ( NSE:ANUHPHR ) shares have been powering on, with a gain of 26% in...
Analysis Article • Apr 04

Fewer Investors Than Expected Jumping On Anuh Pharma Limited (NSE:ANUHPHR)

When close to half the companies in India have price-to-earnings ratios (or "P/E's") above 26x, you may consider Anuh...

Shareholder Returns

ANUHPHRIN PharmaceuticalsIN Market
7D0.5%2.3%2.0%
1Y-17.1%16.0%3.6%

Return vs Industry: ANUHPHR underperformed the Indian Pharmaceuticals industry which returned 16% over the past year.

Return vs Market: ANUHPHR underperformed the Indian Market which returned 3.6% over the past year.

Price Volatility

Is ANUHPHR's price volatile compared to industry and market?
ANUHPHR volatility
ANUHPHR Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.0%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.7%

Stable Share Price: ANUHPHR has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: ANUHPHR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960323Ritesh Shahwww.anuhpharma.com

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs.

Anuh Pharma Limited Fundamentals Summary

How do Anuh Pharma's earnings and revenue compare to its market cap?
ANUHPHR fundamental statistics
Market cap₹7.94b
Earnings (TTM)₹410.46m
Revenue (TTM)₹7.72b
19.4x
P/E Ratio
1.0x
P/S Ratio

Is ANUHPHR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ANUHPHR income statement (TTM)
Revenue₹7.72b
Cost of Revenue₹6.09b
Gross Profit₹1.63b
Other Expenses₹1.22b
Earnings₹410.46m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)4.10
Gross Margin21.13%
Net Profit Margin5.32%
Debt/Equity Ratio0%

How did ANUHPHR perform over the long term?

See historical performance and comparison

Dividends

1.9%
Current Dividend Yield
37%
Payout Ratio

Does ANUHPHR pay a reliable dividends?

See ANUHPHR dividend history and benchmarks
When do you need to buy ANUHPHR by to receive an upcoming dividend?
Anuh Pharma dividend dates
Ex Dividend DateAug 05 2026
Dividend Pay DateSep 11 2026
Days until Ex dividend2 days
Days until Dividend pay date39 days

Does ANUHPHR pay a reliable dividends?

See ANUHPHR dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/02 23:17
End of Day Share Price 2026/07/31 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Anuh Pharma Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research